Phenethyl isothiocynate attenuates Parkinson's disease and improves performance in hanging wire, rotarod and actophotometer test & dopamine levels in rats via inhibiting HDAC-1
Parkinson's disease (PD) is a neurodegenerative disorder that affects overall motor activity due to the loss of dopaminergic neurons in the SNpc (Substantia Nigra Pars Compacta) region of the brain. Despite incessant research and development of new therapeutic agents, management of PD is still...
Saved in:
| Main Authors: | Nikhil More, Angel Godad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Brain Disorders |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666459325000034 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies
by: Wanli Zhang, et al.
Published: (2025-02-01) -
Mechanisms of HDACs in cancer development
by: Ying Zhang, et al.
Published: (2025-04-01) -
Recent Advancements in the Development of HDAC/Tubulin Dual-Targeting Inhibitors
by: Christine Tran, et al.
Published: (2025-02-01) -
Preclinical pharmacokinetics and in vitro ADME properties of PAT-1102: a novel HDAC inhibitor for cancer therapy
by: Chandrashekar Mataguru Doreswamy, et al.
Published: (2025-05-01) -
Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy
by: Yusuf Turkoz, et al.
Published: (2004-01-01)